1. AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy. Issue 5 (May 2015) Authors: Koulis, Christine; Chow, Bryna S.M.; McKelvey, Maria; Steckelings, Ulrike M.; Unger, Thomas; Thallas-Bonke, Vicki; Thomas, Merlin C.; Cooper, Mark E.; Jandeleit-Dahm, Karin A.; Allen, Terri J. Journal: Hypertension Issue: Volume 65:Issue 5(2015:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy. Issue 5 (May 2015) Authors: Koulis, Christine; Chow, Bryna S.M.; McKelvey, Maria; Steckelings, Ulrike M.; Unger, Thomas; Thallas-Bonke, Vicki; Thomas, Merlin C.; Cooper, Mark E.; Jandeleit-Dahm, Karin A.; Allen, Terri J. Journal: Hypertension Issue: Volume 65:Issue 5(2015:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mouse Models for Studying Diabetic Nephropathy. Issue 2 (1st June 2015) Authors: Chow, Bryna S.M.; Allen, Terri J. Journal: Current protocols in mouse biology Issue: Volume 5:Issue 2(2015) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗